Dror Bin, Chief Executive Officer, Israel Innovation Authority

Bankers

Michael Margolis, Senior Managing Director, Head of Healthcare Investment Banking, Oppenheimer & Co.

Michael Rice, Founding Partner, LifeSci Advisors

Venture Capital

Nick Pachuda, MD, General Partner, Neovate Capital Partners

Mitchell Gold, MD, Venture Partner, Frazier Life Scienses

Ittai Harel, Managing Partner, Pitango Venture Capital

Dr. Jing Bao, MD, PhD, Partner, Shanghai Healthcare Capital (SHC)

Dr. Craig Yeshion, MD, Managing Director, Specialty Pharmaceuticals & Medical Devices, Perceptive Advisors

Dr. Boaz Hirshberg, MD, Senior Vice President, Clinical Development Unit Head, Internal Medicine, Regeneron | Regeneron: Relentless Innovation Powering an Impactful Pipeline from Allergy to Obesity and Beyond

HALL A

(I&I) Immunology and Inflammation Reclaim top Priorities in BioPharma: Driver and Opportunities?

Moderators:

Iris Grossman, PhD, Chief Therapeutics Officer, Eleven Therapeutics

Prof. Amnon Peled, PhD, Hadassah Medical Center

Keynote Speakers

Dr. Yael Marantz, PhD, Vice President, VP Nonclinical Development Teva Pharmaceuticals

Mayan Katz, Partner, Tech & Life Sciences Group, Goodwin Procter LLP

Company Presenters

Prof. Dror Harats, MD, CEO & Co-Founder, ImmuneWalk 

Adi Mor, PhD, Co-Founder, CEO, CSO, Chemomab Therapeutics

Prof. Amnon Peled, PhD, Co-Founder, Associate Professor and the Director of the Gene Therapy Institute, Alon Bio

Prof. Rifaat Safadi, MD, Professor, The Hebrew University HEPACURE PHARMA

Kfir Schreiber, Co-Founder & CEO, DeepCure

Jonathan Solomon, CEO, BiomX

Dr. Tali Strauber, MD, Co-Founder, Zelig Therapeuticsת Curing Allergy by Specifically Eliminating Human IgE-Producing B cells

HALL B

Frontiers in Biochip and Bio-Devices: Advancing Technological Systems with Cutting-Edge Biology

Personalized Pathways: Genetic and Cellular Based Advances for Rare and Complex Diseases

1. Keynote Speaker Prof.  Gidi Rechavi– 
Tailoring ASOs for the treatment of rare diseases

2. Personal story – Noam Bomatz –
From Loss to Lifesaving Science: A Personal Journey

3. Dr. Gili Hart – The present and future of Cell and Gene therapies

Part 2 – Gene and Cell therapies short talks 
A. SpliSense – Lital Friedman; VP Clinical & Regulatory Affairs
Title: Transformative RNA Based Treatments for Orphan and Large Unmet Pulmonary
Diseases

B. Lempo Therapeutics – Dr. Oren Glanz; CEO
Title: – Pioneering CRISPR Gene Editing to Calibrate the Immune System and Eliminate
Collateral Damages

C.
Enlivex – Dr. Oren Hershkovitz; CEO
Title: Enlivex-Harnessing the natural healing power of macrophages to treat inflammatory
diseases

D.
Menovia, Dr. Natalie Yivgi Ohana, CEO, 
Title: Mitochondrial Augmentation Technology: updates on Pearson Syndrome and MDS
clinical programs

E. Cytora- Dr. Yona Geffen; CEO
Title: Harnessing the Unique Healing Potential of Human Oral Mucosa Stem Cells for
Treating Complex Multifactorial Diseases

F.
Sheba ( CAR-T )- Jonathan Esensten
Title: Accelerating cell and gene therapies into the clinic with in-house manufacturing at
Sheba Medical Center

Part 3- Panel discussion 
Ayal Hendel– The Israeli eco-system in the era of personalized pathways 

HALL A

Illuminating the Path: Innovations and Challenges in Eye Care

Moderators:

Prof. Anat Loewenstein, MD, President of the Israeli Ophthalmological Society, Dean of the Faculty of Medicine, Tel Aviv University, Chairperson of Ophthalmology, Sourasky Medical Center

Dr. Barak Azmon, MD, Director, Press-By

Jonathan Weyne, MD, Vice President Ophthalmology Therapeutic, Regeneron

Prof. Itay Chowers, Professor of Ophthalmology, & Chairman at the Division of Ophthalmology of the Hadassah – Hebrew University Medical Center

Keynote

Jonathan Weyne, MD, Vice President Ophthalmology Therapeutic, Regeneron  

Company Presenters

Aryeh Batt, CEO & Co-Founder, Precise Bio

Elad Kedar, CEO, Orasis Pharmaceuticals 

Marianna Truman, Co-Founder & CEO, Orsight Pharma

Dana Rabinovich, PhD, Co-Founder & CEO, OphtiMed RX

Prof. (Emeritus) Michael Belkin, MD, Advisor, Former Head of the Ophthalmology Dpt., PBM Medical Technologies, TA

Kester Nahen, CEO, Notal Vision

Nikolai Kunicher, CEO, NeuroTrigger

Daria Lemann Blumenthal, CEO, Nano Drops

Asaf Shiloni, Co-Founder & CEO, XOLTAR

Almog Aley-Raz, Co-Founder, CEO & VP R&D, CorNeat Vision

HALL B

AI’s Next Leap in HealthTech – From Buzzwords (Gen AI, Agentic, LLM and Foundation Models) to Real World examples

Moderator:

Avi Veidman, CEO, Nucleai

Company Presenters

Eliron Amir, CEO, Serial AI/Health Entrepreneur, Rounds Health

Amit Bleiweiss, Senior Data Scientist, NVIDIA

Daniella Gilboa, Co-Founder & CEO, AIVF

Samuel Jefroykin, Director of Data & Research, Eleos Health

Dr. Robert Klempfner, MD, Co-Founder & Chief Medical Officer, AISAP Ltd

Dana Sinai, PhD, Clinical Psychologist, VP Conversational AI, Laguna Health

Shelly Yehezkely, VP of AI, VIZ

HALL C

The Next Bite; Evidence-Based Bio-Food by Design

Moderator: 
Tammy Meiron, PhD, Chief Technology Officer, Fresh Start FoodTech Incubator

Keynote Speakers

Prof. Uri Lesmes, Associate Professor, Technion – Israel Institute of Technology | Smart Reformulation of Food for Health of Different
Populations

Prof. Assaf Zinger, Assistant Professor, Technion – Israel Institute of Technology |Learning from Nature How to Target Diseases

Company Presenters

Ravit Darshan, PhD, CTO, Cinnovir

Eli Faraggi, Co-Founder & CEO, InnoBev | Clinically Proven IP Protected
Ingredients that Improve Focus by Chronobiology

Leehen Mashiah, PhD Student, Technion- Israel Institute of Technology | Sex-Based Variations in the In Vitro Digestibility of
Liquid and Powdered Milk and Oat Alternatives: Implications for Nutritional
Bioaccessibility

Guy Michrowski, Founder & CEO, Profuse | Cultivated Muscle: A New Frontier
for Drug Discovery

Stav Peled, PhD Student, Technion – Israel Institute of Technology | Next-generation prebiotics: selective targeting of proteins to probiotic
bacteria in the colon

Ilan Samish, PhD, Founder & CEO, Amai Proteins | Healthy Sweetener by Precision Fermentation – Backed by Clinical Studied